NASDAQ
Cellyan Biotechnology Co., Ltd (HKPD) has a current ratio of 2.99x as of Monday, May 25, 2026. This represents a 69.30% increase compared to its 12-month average of 1.77x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.